Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?

Glioblastoma remains the most malignant and intrinsically resistant brain tumour in adults. Despite intensive research over the past few decades, through which numerous potentially druggable targets have been identified, virtually all clinical trials of the past 20 years have failed to improve the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Panovska, Dena, De Smet, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369403/
https://www.ncbi.nlm.nih.gov/pubmed/35955765
http://dx.doi.org/10.3390/ijms23158637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369403/
https://www.ncbi.nlm.nih.gov/pubmed/35955765
http://dx.doi.org/10.3390/ijms23158637

Ejemplares similares